Quorum Software is growing fast by adding to its suite of technology by making strategic acquisitions. Getty Images

A Houston software company specializing in cloud-based accounting and finance technology for oil and gas companies is growing at a rapid pace thanks to recent acquisitions.

Houston-based Quorum Software has grown its company over 100 employees last year, and Gene Austin, who was recently named CEO, says it's just the beginning.

The software solutions provider, which is a portfolio company of California-based private equity firm Thoma Bravo LLC since 2018, has big plans to continue the exponential growth with more acquisitions that diversify their portfolio of services and a Houston office expansion later this year.

According to Austin, he expects this growth spurred by M&A activity to double Quorum's revenue of $200 million in the next 3 to 5 years.

"We are always thinking about how to best serve our customers," Austin says. "We've made millions of dollars of investments in our support organization and cloud team services that are foundational to reinvigorate innovation and help our customers see how the future can unfold for them."

Courtesy of Quorum

Quorum is in the midst of a transformation into a software provider, focusing on cloud operations and digital software with significant acquisitions. Most recently, they launched OGsys on Demand, a cloud-based accounting software, after acquiring OGsys in August of 2019. The integration of OGsys expands the cloud-based capabilities for accounting products tailored for upstream medium-sized energy companies.

The launch was right on the heels of two other acquisitions that included Irving, Texas-based Archeio Technologies in June, a document classification smart search technology provider, and Pasadena, Texas-based Coastal Flow Measurement Inc. in March, a family of energy measurement services, one of which was Flow-Cal, a measurement data management software for oil and natural gas.

"Using innovation for us means not only acquiring new technologies but also investing in the right areas for our business and our current products," says Austin.

Quorum, who provides software solutions for a broad spectrum of energy companies' needs, from operations to accounting, plant management, and financial forecasting, began as a consulting firm more than 20 years ago. The company got its start with a customer-oriented structure for large oil and gas companies, known as enterprise organizations in the industry.

Eventually, the business transitioned to working with mid-size firms along with their larger set of clients. It was then when Quorum began to hear from clients their need for better accounting software that met the specific challenges of mid-size companies.

"Our products are designed to help our clients know much more about what's happening inside the business, making sure efficiency is possible," Austin tells InnovationMap. "We're doing that by using web applications that allow our clients to use mobile devices, that's a fairly new innovation in the energy world, we're trying to lead the way."

The focus on quick and efficient software technologies is reaping benefits for Quorum. Eighty percent of the largest oil and gas producers in the United States use Quorum, and its technology powers 80,000 miles of pipeline and that accounts for 80 percent of all-natural gas processed in the U.S.

"We believe because of the products we represent and the way we position our services, including our cloud-based accounting and financial application," Austin says. "We are well-positioned to help our clients do a great job of driving efficiency."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.